Investigational Drug Service is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Investigational Drug Service has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Hemophilia B.
Sponsors: Pfizer.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Investigational Drug Service has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Investigational Drug Service has 1 clinical trials on record, with 1 currently active. Their work covers Hemophilia B.
Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.